Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Clinical trial NCT05563558 · RECRUITING

Trial details

NCT number: NCT05563558
Sponsor: Fundacion Oncosur
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2023-05-05
Primary completion: 2026-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.